Propanc BiopharmaPPCB
13F holders, Q2 2026 (June 30)4holders
1famous investor
$1.49avg. 13F price*
At the end of Q2 2026, 4 institutions reported holding Propanc Biopharma Inc. (PPCB) in their 13F filings. The largest holders were Jane Street Group, LLC ($38K), Citadel Advisors ($18K) and HRT Financial LP ($15K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Propanc Biopharma Inc.
- CUSIP
- 74346N800
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $71K |
| Exits | 0 | $0 |
Ownership 4 holders
| Jane Street Group, LLC | 0.00% | New | 25,550 | $38K |
| Citadel Advisors | 0.00% | New | 12,090 | $18K |
| HRT Financial LP | 0.00% | New | 10,242 | $15K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 2 | $3 |
"% of holder's portfolio" is PPCB's weight in each manager's 13F, not the share of Propanc Biopharma Inc. the manager owns.